BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8741750)

  • 1. Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia.
    Banerjee SP; Zuck LG; Yablonsky-Alter E; Lidsky TI
    Neuroreport; 1995 Dec; 6(18):2500-4. PubMed ID: 8741750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area.
    Schwieler L; Linderholm KR; Nilsson-Todd LK; Erhardt S; Engberg G
    Life Sci; 2008 Aug; 83(5-6):170-5. PubMed ID: 18590745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats.
    Spurney CF; Baca SM; Murray AM; Jaskiw GE; Kleinman JE; Hyde TM
    Synapse; 1999 Dec; 34(4):266-76. PubMed ID: 10529721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
    Arvanov VL; Wang RY
    J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.
    Yu J; Källström L; Wiesel FA; Johnson AE
    Synapse; 1999 Dec; 34(3):192-207. PubMed ID: 10523757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine-antipsychotic drug interactions and attentional performance in female rats.
    Rezvani AH; Levin ED
    Eur J Pharmacol; 2004 Feb; 486(2):175-82. PubMed ID: 14975706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle.
    Prus AJ; Philibin SD; Pehrson AL; Porter JH
    Behav Pharmacol; 2006 Mar; 17(2):185-94. PubMed ID: 16495726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine.
    Meador-Woodruff JH; King RE; Damask SP; Bovenkerk KA
    Mol Psychiatry; 1996 Mar; 1(1):41-53. PubMed ID: 9118313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.
    Heresco-Levy U
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1113-23. PubMed ID: 14642971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.
    Huerta I; McCullumsmith RE; Haroutunian V; Giménez-Amaya JM; Meador-Woodruff JH
    Synapse; 2006 Jun; 59(7):394-402. PubMed ID: 16485262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol.
    Millan MJ; Brocco M; Gobert A; Schreiber R; Dekeyne A
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1002-14. PubMed ID: 10027837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.
    Schwieler L; Engberg G; Erhardt S
    Synapse; 2004 May; 52(2):114-22. PubMed ID: 15034917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
    Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
    Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.